Vesugen
C₁₃H₂₂N₄O₆
Tripeptide bioregulator studied for vascular endothelial function and blood vessel health.
Select Size
Quantity
Vesugen (Lys-Glu-Asp) is a vascular-targeting tripeptide bioregulator developed by Khavinson. Research has focused on its effects on vascular endothelial gene expression, blood vessel wall integrity, and microcirculation. Studies have demonstrated effects on endothelial cell proliferation and vascular tone regulation, with applications in age-related vascular decline research.
Related Compounds
Research Use Only — Legal Disclaimer
All products sold by Halo Peptides are strictly intended for in-vitro research, laboratory use, and scientific investigation only. They are not intended for human consumption, veterinary use, diagnostic purposes, or any therapeutic application. By browsing this website and purchasing any product, you acknowledge and agree that you are a qualified researcher and will use all compounds in compliance with applicable local, national, and international laws and regulations.